Effects of prostanoid ep agonists on mouse intraocular pressure

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2201-2208

  Saeki, Tadashiro ^a   Ota, Takashi ^a   Aihara, Makoto ^a   Araie, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; ONO AE 1 259 01; ONO AE 1 329; ONO AE 248; ONO DI 004; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN E2 AGONIST; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; 9 DEOXY 9 CHLORO 15 DEOXY 16 HYDROXY 17,17 TRIMETHYLENE 19,20 DIDEHYDROPROSTAGLANDIN E2; 9-DEOXY-9-CHLORO-15-DEOXY-16-HYDROXY-17,17-TRIMETHYLENE-19,20-DIDEHYDROPROSTAGLANDIN E2; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; ETHER DERIVATIVE; ONO AE1 329; ONO-AE1-329; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN F;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAOCULAR PRESSURE; KNOCKOUT MOUSE; MICROPIPETTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; AQUEOUS HUMOR; C57BL MOUSE; DRUG EFFECT; DRUG POTENTIATION; INTRAOCULAR HYPOTENSION; MOUSE MUTANT; OCULOPLETHYSMOGRAPHY; SECRETION; TIME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRAOCULAR PRESSURE; METHYL ETHERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OCULAR HYPOTENSION; PROSTAGLANDINS F, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E; TIME FACTORS; TONOMETRY, OCULAR;

EID: 65549140758     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2800     Document Type: Article

References (58)

1. Coleman RA, Kennedy I. Characterisation of the prostanoid recep- tors mediating contraction of guinea-pig isolated trachea. Prostaglandins. 1985;29:363-375.
2. Conquet P, Plazonnet B, Le Douarec JC. Arachidonic acid-induced elevation of intraocular pressure and anti-inflammatory agents. Invest Ophthalmol. 1975;14:772-775.
3. Kremer M, Baikoff G, Charbonnel B. The release of prostaglandins in human aqueous humour following intraocular surgery: effect of indomethacin. Prostaglandins. 1982;23:695-702.
4. Kulkarni PS, Srinivasan BD. The effect of intravitreal and topical prostaglandins on intraocular inflammation. Invest Ophthalmol Vis Sci. 1982;23:383-392.
5. Camras CB, Podos SM. The role of endogenous prostaglandins in clinically-used and investigational glaucoma therapy. Prog Clin Biol Res. 1989;312:459-475.
6. Sakurai M, Araie M, Oshika T, et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol. 1991;35:156-165.
7. Crowston JG, Lindsey JD, Aihara M, Weinreb RN. Effect of latano- prost on intraocular pressure in mice lacking the prostaglandin FP receptor. Invest Ophthalmol Vis Sci. 2004;45:3555-3559.
8. Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2005;46:4159-4163.
9. Gabelt BT, Seeman JL, Podos SM, Mittag TW, Kaufman PL. Aqueous humor dynamics in monkeys after topical 8-iso PGE(2). Invest Ophthalmol Vis Sci. 2004;45:892-899.
10. Serle JB, Wang RF, Mittag TW, Shen F, Podos SM. Effect of pilo- carpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glauco- matous monkey eyes. J Glaucoma. 2001;10:215-219.
11. Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB, Becker B. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Arch Ophthalmol. 1998;116:1213-1216.
12. Wang RF, Podos SM, Serle JB, Mittag TW, Ventosa F, Becker B. Effect of latanoprost or 8-iso prostaglandin E2 alone and in combination on intraocular pressure in glaucomatous monkey eyes. Arch Ophthalmol. 2000;118:74-77.
13. Yousufzai SY, Ye Z, Abdel-Latif AA. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res. 1996;63:305-310.
14. Kashiwagi K, Kanai N, Tsuchida T, et al. Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocu- lar metabolism. Exp Eye Res. 2002;74:41-49.
15. Hinz B, Rosch S, Ramer R, Tamm ER, Brune K. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J. 2005;19:1929-1931.
16. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997; 38:2772-2780.
17. Ota T, Aihara M, Saeki T, Narumiya S, Araie M. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Invest Ophthalmol Vis Sci. 2006;47:3395-3399.
18. Hizaki H, Segi E, Sugimoto Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci U S A. 1999;96:10501-10506.
19. Sugimoto Y, Yamasaki A, Segi E, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 1997;277:681-683.
20. Ushikubi F, Segi E, Sugimoto Y, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature. 1998;395:281-284.
21. Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun. 1998;246:7-12.
22. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 1997;122:217-224.
23. Tsuboi K, Sugimoto Y, Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat. 2002;68-69:535-556.
24. Aihara M, Lindsey JD, Weinreb RN. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
25. Ota T, Murata H, Sugimoto E, Aihara M, Araie M. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci. 2005;46:2006-2011.
26. Crowston JG, Aihara M, Lindsey JD, Weinreb RN. Effect of latano-prost on outflow facility in the mouse. Invest Ophthalmol Vis Sci. 2004;45:2240-2245.
27. Aihara M, Lindsey JD, Weinreb RN. Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci. 2003;44:5168-5173.
28. Barany EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the Vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
29. Bill A. Conventional and uveo-scleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high in- traocular pressures. Exp Eye Res. 1966;5:45-54.
30. Pederson JE, Gaasterland DE, MacLellan HM. Uveoscleral aqueous outflow in the rhesus monkey: importance of uveal reabsorption. Invest Ophthalmol Vis Sci. 1977;16:1008-1017.
31. Eakins KE. Prostaglandin and non-prostaglandin mediated break-down of the blood-aqueous barrier. Exp Eye Res. 1977;25(suppl): 483-498.
32. Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rab- bits. Invest Ophthalmol Vis Sci. 1977;16:1125-1134.
33. Biswas S, Bhattacherjee P, Paterson CA. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues-a comparative immunohistochemical study. Prostaglan- dins Leukot Essent Fatty Acids. 2004;71:277-288.
34. Kamphuis W, Schneemann A, van Beek LM, Smit AB, Hoyng PF, Koya E. Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. In- vest Ophthalmol Vis Sci. 2001;42:3209-3215.
35. Mukhopadhyay P, Geoghegan TE, Patil RV, Bhattacherjee P, Paterson CA. Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem Pharmacol. 1997;53: 1249-1255.
36. Schlotzer-Schrehardt U, Zenkel M, Nusing RM. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci. 2002;43:1475-1487.
37. Takamatsu M, Hotehama Y, Goh Y, Mishima HK. Localization of prostaglandin E receptor subtypes in the ciliary body of mouse eye. Exp Eye Res. 2000;70:623-628.
38. Tabata H, Tanaka S, Sugimoto Y, Kanki H, Kaneko S, Ichikawa A. Possible coupling of prostaglandin E receptor EP(1) to TRP5 ex- pressed in Xenopus laevis oocytes. Biochem Biophys Res Com- mun. 2002;298:398-402.
39. Katoh H, Watabe A, Sugimoto Y, Ichikawa A, Negishi M. Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. Biochim Biophys Acta. 1995;1244:41-48.
40. Okada Y, Hara A, Ma H, et al. Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors. Br J Pharmacol. 2000;131:745-755.
41. Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther. 2003;19:501-515.
42. Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci. 2003;74:143-153.
43. Katsuyama M, Nishigaki N, Sugimoto Y, et al. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 1995;372:151-156.
44. Negishi M, Sugimoto Y, Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta. 1995;1259:109-119.
45. Smith GC, McGrath JC. Contractile effects of prostanoids on fetal rabbit ductus arteriosus. J Cardiovasc Pharmacol. 1995;25:113-118.
46. Coleman RA, Mallett A, Sheldrick RL. EP4-receptors and cyclic AMP in pig venous smooth muscle: evidence with agonists and the EP4-antagonist, AH22921. Adv Prostaglandin Thromboxane Leu- kot Res. 1995;23:241-246.
47. Fujimoto N, Zhao C, Shichi H. The effects of prostaglandins E2 and F2 alpha on porcine ciliary muscle cells in culture. Curr Eye Res. 1995;14:1155-1163.
48. Anthony TL, Lindsey JD, Weinreb RN. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest Ophthalmol Vis Sci. 2002;43:3705-3711.
49. Weinreb RN, Lindsey JD. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:716-722.
50. Rosch S, Ramer R, Brune K, Hinz B. Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary ep- ithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases. Biochem Biophys Res Commun. 2005;338: 1171-1178.
51. Nilsson SF, Drecoll E, Lutjen-Drecoll E, et al. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 2006;47:4042-4049.
52. Irie A, Sugimoto Y, Namba T, et al. Third isoform of the prostag-landin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur J Biochem. 1993;217:313-318.
53. Nishigaki N, Negishi M, Sugimoto Y, Namba T, Narumiya S, Ichikawa A. Characterization of the prostaglandin E receptor expressed on a cultured mast cell line, BNu-2cl3. Biochem Pharma- col. 1993;46:863-869.
54. Sugimoto Y, Negishi M, Hayashi Y, et al. Two isoforms of the EP3 receptor with different carboxyl-terminal domains: identical ligand binding properties and different coupling properties with Gi proteins. J Biol Chem. 1993;268:2712-2718.
55. Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L. Stimula- tory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells. Eur J Pharmacol. 1993;237: 131-137.
56. Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med. 1983;172:214-218.
57. Seno H, Oshima M, Ishikawa TO, et al. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc- (Delta716) mouse intestinal polyps. Cancer Res. 2002;62:506-511.
58. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin- 1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. J Biol Chem. 2004;279:46700-46705.